Baxalta (United States)
Baxalta is a biopharmaceutical company founded on 1 July 2015 after its parent company, Baxter International, spun off biopharmaceutical division. The company began its operation with a revenue of $6 billion, and is now a subsidiary of Takeda Pharmaceutical Company. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Baxalta (United States), United States, covering academic research published from 2000 to 2025. Read More.
Open Access Percentage
42%
Total
Publications
335
Total Open
Publications
142
Total
Citations
7.9K
Open Access
Percentage
42%
Total
Publications
335
Total Open
Publications
142
Total
Citations
7.9K
Breakdown
Publisher Open
19%
Both
19%
Other Platform Open
4%
Closed
58%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 24%
30
Hybrid 29%
36
No Guarantees 47%
59
Other Platform Open
Domain 76%
56
Institution 42%
31
Preprint 4%
3
Other Internet 4%
3
Public 3%
2
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 56 |
California Digital Library | Institution | 17 |
doaj.org OAI-PMH Repository | Institution | 11 |
DOI | Other Internet | 3 |
Utrecht University | Institution | 2 |
University of Edinburgh | Institution | 2 |
University of Bristol | Institution | 2 |
Royal Netherlands Academy of Arts and Sciences | Institution | 2 |
Research Square | Preprint | 2 |
Zenodo | Public | 1 |